Abstract
This commentary discusses a study reported by Kumar et al. that compared outcomes of 56 patients with autosomal dominant polycystic kidney disease (ADPKD) started on peritoneal dialysis with those of a control group of nondiabetic patients matched for age, sex and year of starting peritoneal dialysis. During follow-up (mean 37 months), patient survival, technique survival and peritonitis rates were similar in the two groups. Peritoneal dialysis was not only possible but was also successful in 68% of patients. Although the study was well conducted and the results very encouraging, it did not address the relevant clinical issue of whether peritoneal dialysis is a less desirable option than hemodialysis in some patients with ADPKD, for example those with very large, cystic kidneys and/or a very large, cystic liver. Further studies to investigate renal replacement modalities in patients with ADPKD should relate study outcomes to the volumes of patients' kidneys and liver.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Peritoneal dialysis as a treatment option in autosomal dominant polycystic kidney disease
International Urology and Nephrology Open Access 19 August 2015
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
del Peso G et al. (2003) Risk factors for abdominal wall complications in peritoneal dialysis patients. Perit Dial Int 23: 249–254
Fletcher S et al. (1994) Increased incidence of hydrothorax complicating peritoneal dialysis in patients with adult polycystic kidney disease. Nephrol Dial Transplant 9: 832–833
Hadimeri H et al. (1998) CAPD in patients with autosomal dominant polycystic kidney disease. Perit Dial Int 18: 429–432
Pandya BK et al. (2004) A comparison of peritonitis in polycystic and non-polycystic patients on peritoneal dialysis. Perit Dial Int 24: 79–81
Kumar S et al. (2008) Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis. Kidney Int 74: 946–951
Pirson Y et al. (2002) Treatment of patients with hereditary and congenital disorders. In Optimal Strategies of Treatment for End-Stage Renal Failure, 205–208 (Ed. Jacobs C) Oxford: Oxford University Press
Abbott KC and Agodoa LY (2002) Polycystic kidney disease at end-stage renal disease in the United States: patient characteristics and survival. Clin Nephrol 57: 208–214
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
E Goffin has declared an association with the following company: Baxter Healthcare, Belgium (speakers bureau and grant/research support). Y Pirson declared no competing interests.
Rights and permissions
About this article
Cite this article
Goffin, E., Pirson, Y. Is peritoneal dialysis a suitable renal replacement therapy in autosomal dominant polycystic kidney disease?. Nat Rev Nephrol 5, 122–123 (2009). https://doi.org/10.1038/ncpneph1037
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpneph1037
This article is cited by
-
Peritoneal dialysis as a treatment option in autosomal dominant polycystic kidney disease
International Urology and Nephrology (2015)